Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy

Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to...

Full description

Bibliographic Details
Published in:	Diagnostics
Main Authors:	Miki Kawano, Yoshihiko Yano, Atsushi Yamamoto, Eiichiro Yasutomi, Yuta Inoue, Jun Kitadai, Ryutaro Yoshida, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	immune checkpoint inhibitor liver injury DILI histology
Online Access:	https://www.mdpi.com/2075-4418/14/8/815

Similar Items

Development of a Predictive Model for Classifying Immune Checkpoint Inhibitor‐Induced Liver Injury Types
by: Jun Kitadai, et al.
Published: (2025-04-01)

Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen
by: Yoshihiko Yano, et al.
Published: (2024-03-01)

Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective Study
by: Gina Gualano, et al.
Published: (2023-11-01)

Treatment of Drug-Induced Liver Injury
by: Rolf Teschke
Published: (2022-12-01)

Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
by: Ahmed K. Saleh, et al.
Published: (2025-03-01)

Higher Absolute Lymphocyte Counts and Lower Des‐γ‐Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma
by: Yuta Inoue, et al.
Published: (2025-02-01)

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
by: Shike Lou, et al.
Published: (2024-08-01)

BASIN DİLİ ÜZERİNE BAZI DİKKATLER
by: ersin özarslan
Published: (2014-02-01)

BASIN DİLİ ÜZERİNE BAZI DİKKATLER
by: ersin özarslan
Published: (2014-02-01)

Progress in the treatment of drug-induced liver injury with natural products
by: Yuan-kai Sun, et al.
Published: (2022-09-01)

Lorazepam causing drug-induced liver injury : Rare entity
by: S. Sellami, et al.
Published: (2021-04-01)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
by: Marta Moreno-Torres, et al.
Published: (2022-06-01)

Mechanism and regulation of mitophagy in liver diseases: a review
by: Sen Liu, et al.
Published: (2025-06-01)

Drug-induced liver injury (DILI) - mechanisms and diagnostic
by: Marta Małysz, et al.
Published: (2022-10-01)

Predictability of drug-induced liver injury by machine learning
by: Marco Chierici, et al.
Published: (2020-02-01)

The Morphological and Histopathological Liver Abnormalities Caused by Carbamazepine-Induced Injury in Female Albino Mice
by: Nawar R. Jaber, et al.
Published: (2024-05-01)

Evaluation of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in drug-induced liver injury
by: Omkolsoum Alhaddad, et al.
Published: (2024-09-01)

Drug-induced liver injury: Relation between the R ratio and histopathology
by: O.M. Ardila-Suárez, et al.
Published: (2023-01-01)

iDILI-MT: identifying drug-induced liver injury compounds with a multi-head Transformer
by: Wanrong Zheng, et al.
Published: (2025-06-01)

Liver Injury Associated with Antituberculosis Medications
by: Syifa Mustika, et al.
Published: (2025-07-01)

COVID-19-Associated Liver Injury
by: Gildea DT, et al.
Published: (2023-02-01)

Legionnaires' disease on azithromycin leading to lofty liver levels
by: Sagar Modh, et al.
Published: (2025-01-01)

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
by: Yoshihiko Yano, et al.
Published: (2023-07-01)

NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
by: Ana M. Benedicto, et al.
Published: (2021-07-01)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
by: Péter Tátrai, et al.
Published: (2022-12-01)

Spatial Computational Hepatic Molecular Biomarker Reveals LSEC Role in Midlobular Liver Zonation Fibrosis in DILI and NASH Liver Injury
by: Munish Puri
Published: (2024-03-01)

The role of exosomal lncRNAs in acetaminophen-induced induced liver injury in SD rats
by: Zixuan Yang, et al.
Published: (2024-12-01)

The LiverTox Paradox-Gaps between Promised Data and Reality Check
by: Rolf Teschke, et al.
Published: (2021-09-01)

The Incidence and Risk Factor Analysis of Drug Induced Liver Injury (Dili) in a Surabaya Hospital
by: Sherly Tandi Arrang, et al.
Published: (2018-10-01)

High-throughput screening of novel TFEB agonists in protecting against acetaminophen-induced liver injury in mice
by: Xiaojuan Chao, et al.
Published: (2024-01-01)

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
by: Marina Villanueva-Paz, et al.
Published: (2021-03-01)

Dual roles of p62/SQSTM1 in the injury and recovery phases of acetaminophen-induced liver injury in mice
by: Hui Qian, et al.
Published: (2021-12-01)

Liver-on-chips for drug discovery and development
by: Viraj Mehta, et al.
Published: (2024-08-01)

Spatial modeling reveals nuclear phosphorylation and subcellular shuttling of YAP upon drug-induced liver injury
by: Lilija Wehling, et al.
Published: (2022-10-01)

Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation
by: Benoit Cox, et al.
Published: (2022-08-01)

From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders
by: Yuqi He, et al.
Published: (2025-03-01)

Beden Dili Çalışmalarında Unutulan Bir Eser: “Yüz İfadelerinin Tefsiri Hakkında Tecrübi Bir Tetkik”
by: Ozan İpek
Published: (2017-07-01)

Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures for early mortality in acute liver failure
by: Neha Sharma, et al.
Published: (2025-10-01)

Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method
by: Rolf Teschke, et al.
Published: (2024-04-01)

Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
by: K. Taylor, et al.
Published: (2025-02-01)